Hundreds of pharmaceutical firms including Pfizer wrote an open letter condemning a federal judge in Texas who halted the approval of abortion drug mifepristone.
Lawyers who filed a lawsuit challenging the FDAs approval of a popular abortion drug respond to critics who say filing the suit in Texas is judge shopping.
Hundreds of pharmaceutical and biotech company executives signed an open letter Monday condemning a federal judge in Texas for halting theTrump-appointed U.S. District Judge Matthew J. Kacsmarykdirecting the FDA to halt the approval while a lawsuit challenging its safety and approval works its way through court.
Mifepristone and Misoprostol, the two drugs used in a medication abortion, are seen at the Women's Reproductive Clinic, which provides legal medication abortion services, in Santa Teresa, New Mexico, on June 17, 2022. Kacsmaryk stayed the FDA's approval of the abortion drug, but gave the federal government seven days to "seek emergency relief from the United States Court of Appeals for the Fifth Circuit."
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Pfizer, hundreds of US drugmakers call for reversal of Texas abortion pill rulingOver 300 biotech and pharmaceutical industry executives, including Pfizer Inc CEO Albert Bourla, signed an open letter on Monday calling for reversal of a federal judge's decision to suspend sales of the abortion pill mifepristone.
Weiterlesen »
More than 200 drugmakers led by Pfizer blast Texas judge's abortion pill decisionMore than 200 drugmakers led by Pfizer have signed an open letter blasting the decision by a federal judge in Texas to issue a hold on federal approval of mifepristone, the most commonly used method of abortion in the U.S.
Weiterlesen »
Pfizer, Biogen among hundreds of US drugmakers calling for abortion pill ruling reversalExecutives from more than 300 biotech and pharmaceutical industry companies, including Pfizer Inc and Biogen Inc , signed an open letter on Monday calling for reversal of a federal judge's decision to suspend sales of the abortion pill mifepristone.
Weiterlesen »
Hundreds of pharma execs call for reversal of Texas abortion pill rulingOne of the pharmaceutical industry’s central concerns is that if a judge can overturn FDA approval of Mifepristone, all drugs are vulnerable to similar rulings.
Weiterlesen »
What is mifepristone, the drug at the heart of the Texas medication abortion lawsuit?A federal judge in Texas has said he will suspend the approval of mifepristone, a drug approved by the US Food and Drug Administration that has been shown to be safe and effective for more than two decades.
Weiterlesen »
Analysis: Texas abortion pill ruling could undermine US drug regulatorA federal judge's decision last week to suspend the U.S. Food and Drug Administration's (FDA) approval of abortion pill mifepristone could severely weaken the agency if allowed to stand, health policy and legal experts said.
Weiterlesen »